Literature DB >> 18343605

[Consciousness disorders and severe haemolytic anaemia in a patient coming from overseas].

C Garcia-Hejl1, H Thefenne-Astier, J-C Navarrot, E Batjom, E Nicand, Y Ricordel, J M Ramirez, L Brinquin.   

Abstract

A 54-years-old patient coming from Guinea, who presented fever, diarrhoea, consciousness disorders and severe haemolytic anaemia, was admitted to resuscitation unit in France. Despite many explorations carried out (evaluation of traumatic causes, infection, neoplasia, vascular, toxic causes, vitamin deficiency), it was not possible to explain neurological symptomatology. Besides, haemolytic anaemia was due to the ingestion of metamizole in a context of glucose-6-phosphate dehydrogenase deficit. This drug's marketing has been suspended in France since 2006. Despite appropriate treatment, after seven days of hospitalization, the patient died of multi-organ failure and hemophagocytic syndrome. This clinical case illustrates the difficulties encountered to set a diagnosis and manage patients coming from overseas. Uncommon aetiologies for French healthcare professionals should be evoked in the absence of comprehensive clinical information.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343605     DOI: 10.1016/j.patbio.2008.01.003

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  2 in total

1.  STXBP2-R190C Variant in a Patient With Neonatal Hemophagocytic Lymphohistiocytosis (HLH) and G6PD Deficiency Reveals a Critical Role of STXBP2 Domain 2 on Granule Exocytosis.

Authors:  Nathalia Benavides; Waldo A Spessott; Maria L Sanmillan; Marcelo Vargas; Mylynda S Livingston; Nissa Erickson; Tamara C Pozos; Margaret E McCormick; Emilia Scharrig; Yoav H Messinger; Claudio G Giraudo
Journal:  Front Immunol       Date:  2020-10-08       Impact factor: 7.561

2.  Case Report: Leishmania and HIV Co-Diagnosis: How to Understand Medical History?

Authors:  Arthur Dujardin; Arnaud de La Blanchardière; Julia Dina; Karl Stefic; Christophe Ravel; Julie Bonhomme; Renaud Verdon; Anna Lucie Fournier
Journal:  Front Immunol       Date:  2021-04-21       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.